DAPSONE 8.5% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC]

  • Home
  • DAPSONE 8.5% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC]

DAPSONE 8.5% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC]
PDF | XML
NDC 72934-1066-2
Set ID 8738b667-e55b-5543-e053-2991aa0a5530
Category HUMAN PRESCRIPTION DRUG LABEL
Packager Sincerus Florida, LLC
Generic Name
Product Class
Product Number
Application Number
View All Sections
  • Directions for use

    f

  • Sincerus Florida, LLC adverse reactions.

    s

  • Active, inactive

    d

  • NDC 72934-1066-2 DAPSONE 8.5 / NIACINAMIDE 4 Gel 30gm

    d

  • INGREDIENTS AND APPEARANCE
    DAPSONE 8.5% / NIACINAMIDE 4% 
    dapsone 8.5% / niacinamide 4% gel
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-1066
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DAPSONE (UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302) DAPSONE8.5 g  in 100 g
    NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72934-1066-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/01/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/01/2019
    Labeler - Sincerus Florida, LLC (080105003)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sincerus Florida, LLC080105003manufacture(72934-1066)
View All Sections

Related Drugs

Search DailyMed Drugs